Literature DB >> 18240147

Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.

Takeshi Nagasaka1, Ajay Goel, Kenji Notohara, Takaomi Takahata, Hiromi Sasamoto, Takuyuki Uchida, Naoshi Nishida, Noriaki Tanaka, Clement Richard Boland, Nagahide Matsubara.   

Abstract

O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair gene which is frequently methylated in colorectal cancer (CRC). However, it remains controversial whether methylation of specific CpG sequences within MGMT promoter leads to loss of its protein expression, and if MGMT methylation correlates with G to A transition mutations in KRAS. Two methylation sensitive regions (Mp and Eh region) of MGMT promoter were investigated in 593 specimens of colorectal tissue: 233 CRCs, 104 adenomatous polyps (AP), 220 normal colonic mucosa from CRC patients (N-C) and 36 normal colonic mucosa specimens obtained from subjects without colorectal neoplasia (N-N) by combined bisulfite restriction analysis (COBRA). The region-specific methylation data were compared to the MGMT protein expression, spectrum of KRAS mutations and other clinical features. Extensive (including both Mp and Eh) and partial (either Mp or Eh) MGMT methylation were found in 24.5% and 11.6% of CRCs, 3.8% and 27.9% of APs, 0.5% and 7.7% of C-Ns and 2.8% and 2.8% of N-Ns, respectively. Extensive methylation of MGMT promoter was primarily present in CRCs while partial methylation was common in APs. Extensive methylation of MGMT promoter was associated with loss/reduced protein expression (p < 0.0001), as well as with G to A mutations in KRAS (p = 0.0017). We herein provide first evidence that extensive methylation of MGMT promoter region is essential for methylation-induced silencing of this gene. Our data suggest that MGMT methylation may evolve and spread throughout the promoter in a stepwise manner as the colonic epithelial cells progress through the classical-adenoma-cancer multistep cascade. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240147      PMCID: PMC2851179          DOI: 10.1002/ijc.23398

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 2.  Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

Authors:  A E Pegg
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

3.  Colorectal cancer screening: clinical guidelines and rationale.

Authors:  S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene.

Authors:  L C Harris; P M Potter; K Tano; S Shiota; S Mitra; T P Brent
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

6.  Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Authors:  Leah C Pulling; Kevin K Divine; Donna M Klinge; Frank D Gilliland; Terri Kang; Ann G Schwartz; Therese J Bocklage; Steven A Belinsky
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

7.  Expression of the endogenous O6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions.

Authors:  G Aquilina; R Biondo; E Dogliotti; M Meuth; M Bignami
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

8.  Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.

Authors:  Takeshi Nagasaka; Gerald B Sharp; Kenji Notohara; Takeshi Kambara; Hiromi Sasamoto; Hiroshi Isozaki; Donald G MacPhee; Jeremy R Jass; Noriaki Tanaka; Nagahide Matsubara
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

9.  In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription.

Authors:  L C Harris; J S Remack; T P Brent
Journal:  Biochim Biophys Acta       Date:  1994-03-01

10.  Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.

Authors:  Monika E Hegi; Annie-Claire Diserens; Sophie Godard; Pierre-Yves Dietrich; Luca Regli; Sandrine Ostermann; Philippe Otten; Guy Van Melle; Nicolas de Tribolet; Roger Stupp
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more
  35 in total

1.  Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.

Authors:  Hamdy E Abouzeid; Abdel Meguid Kassem; Abdel Hady Abdel Wahab; Hatem A El-mezayen; Hayaat Sharad; Shaimaa Abdel Rahman
Journal:  Tumour Biol       Date:  2011-01-28

2.  Familial colorectal cancer type X syndrome: two distinct molecular entities?

Authors:  Inês Francisco; Cristina Albuquerque; Pedro Lage; Hélio Belo; Inês Vitoriano; Bruno Filipe; Isabel Claro; Sara Ferreira; Paula Rodrigues; Paula Chaves; Carlos Nobre Leitão; António Dias Pereira
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 3.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

4.  Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer.

Authors:  Quan Wang; Peilin Jia; Feixiong Cheng; Zhongming Zhao
Journal:  Genes Chromosomes Cancer       Date:  2014-11-19       Impact factor: 5.006

5.  The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Authors:  Katherine Baran; Mao Yang; Christopher P Dillon; Leona L Samson; Douglas R Green
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

Review 6.  Promoter methylation in the genesis of gastrointestinal cancer.

Authors:  Clement Richard Boland; Sung Kwan Shin; Ajay Goel
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

7.  Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.

Authors:  Takeshi Nagasaka; Noriaki Tanaka; Harry M Cullings; Dong-Sheng Sun; Hiromi Sasamoto; Takuyuki Uchida; Minoru Koi; Naoshi Nishida; Yoshio Naomoto; C Richard Boland; Nagahide Matsubara; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2009-08-21       Impact factor: 13.506

Review 8.  Epigenetics of colorectal cancer.

Authors:  Ajay Goel; C Richard Boland
Journal:  Gastroenterology       Date:  2012-09-20       Impact factor: 22.682

9.  Quantitation of DNA methylation by melt curve analysis.

Authors:  Eric Smith; Michael E Jones; Paul A Drew
Journal:  BMC Cancer       Date:  2009-04-24       Impact factor: 4.430

10.  Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.

Authors:  Victoria Gonzalo; Juan José Lozano; Jenifer Muñoz; Francesc Balaguer; Maria Pellisé; Cristina Rodríguez de Miguel; Montserrat Andreu; Rodrigo Jover; Xavier Llor; M Dolores Giráldez; Teresa Ocaña; Anna Serradesanferm; Virginia Alonso-Espinaco; Mireya Jimeno; Miriam Cuatrecasas; Oriol Sendino; Sergi Castellví-Bel; Antoni Castells
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.